| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.028 | 0.9 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.0064 | 0.9 |